Referable Macular Hemorrhage-A Clinically Meaningful Screening Target in Newborn Infants. Position Statement of the Association of Pediatric Retina Surgeons

---

Copy For Citation

Wood E. H., Capone A., Drenser K. A., Berrocal A., Hubbard G. B., Callaway N. F., ...More

OPHTHALMIC SURGERY LASERS & IMAGING RETINA, vol.53, no.1, pp.3-6, 2022 (SCI-Expanded)

• Publication Type: Article / Editorial Material
• Volume: 53 Issue: 1
• Publication Date: 2022
• Doi Number: 10.3928/23258160-20211214-01
• Journal Name: OPHTHALMIC SURGERY LASERS & IMAGING RETINA
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Page Numbers: pp.3-6
• Gazi University Affiliated: No

Abstract

Universal newborn eye screening facilitates early diagnosis of ocular abnormalities and mitigates vision loss. "Referral warranted" eye disease is present at birth in about 5.5% of term infants, with "macular hemorrhage impinging on the fovea" representing about 50% of referral warranted disease. The Association of Pediatric Retina Surgeons held a symposium on February 9, 2021 that culminated in a position statement on "referable macular hemorrhage" (RMH) in newborn infants. RMH is meaningful in that in can cause amblyopia through deprivation, can be readily captured with wide-angle photography in a safe and efficient manner, and may lead to early intervention with mitigation of vision loss.